Self-reactive antibodies (natural autoantibodies) in healthy individuals

被引:258
作者
Lacroix-Desmazes, S [1 ]
Kaveri, SV
Mouthon, L
Ayouba, A
Malanchere, E
Coutinho, A
Kazatchkine, MD
机构
[1] Hop Broussais, INSERM, U430, F-75674 Paris, France
[2] Univ Paris 06, Paris, France
[3] Inst Pasteur, CNRS, URA 1961, Paris, France
关键词
natural autoantibodies; autoreactivity; repertoires; immunoglobulins;
D O I
10.1016/S0022-1759(98)00074-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Antibodies that are present in the serum of healthy individuals in the absence of deliberate immunization with any antigen, are refered to as natural antibodies. A vast majority of natural antibodies react with one or more self antigens and are termed as natural autoantibodies. The importance of natural autoantibodies in immune regulation has long been neglected, since tolerance to self was thought to be primarily dependent on the deletion of autoreactive clones, rather than on peripheral suppressive mechanisms. Clonal deletion and energy cannot account, however, for the prevalence of natural autoreactivity among healthy individuals. It is now well established that autoreactive antibodies and B cells, and autoreactive T cells, are present in healthy individuals, and in virtually all vertebrate species. Autoreactive repertoires are predominantly selected early in ontogeny. Questions pertaining to the role of natural antibodies in the regulation of the immune response and maintenance of immune homeostasis and to the distinction between natural autoreactivity and pathological autoimmunity have not been adequately addressed. Here, we focus on the current knowledge on the physicochemical and functional properties of NAA in man, and the use of NAA for therapeutic intervention. (C) 1998 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:117 / 137
页数:21
相关论文
共 201 条
[51]  
DIGHIERO G, 1986, J IMMUNOL, V136, P4000
[52]  
DIGHIERO G, 1983, J IMMUNOL, V131, P2267
[53]   BLOCKING IL-1 - INTERLEUKIN-1 RECEPTOR ANTAGONIST INVIVO AND INVITRO [J].
DINARELLO, CA ;
THOMPSON, RC .
IMMUNOLOGY TODAY, 1991, 12 (11) :404-410
[54]   IS THERE A ROLE FOR INTERLEUKIN-1 BLOCKADE IN INTRAVENOUS IMMUNOGLOBULIN THERAPY [J].
DINARELLO, CA .
IMMUNOLOGICAL REVIEWS, 1994, 139 :173-188
[55]   INDUCTION BY ANTI-CD40 ANTIBODY OR SOLUBLE CD40 LIGAND AND CYTOKINES OF IGG, IGA AND IGE PRODUCTION BY B-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME [J].
DURANDY, A ;
SCHIFF, C ;
BONNEFOY, JY ;
FORVEILLE, M ;
ROUSSET, F ;
MAZZEI, G ;
MILILI, M ;
FISCHER, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2294-2299
[56]  
DURANDY A, 1990, J IMMUNOL, V144, P60
[57]   NATURALLY-OCCURRING ANTI-IDIOTYPIC ANTIBODIES IN MYASTHENIA-GRAVIS PATIENTS [J].
DWYER, DS ;
BRADLEY, RJ ;
URQUHART, CK ;
KEARNEY, JF .
NATURE, 1983, 301 (5901) :611-614
[58]  
Elson C J, 1979, Int Rev Exp Pathol, V19, P137
[59]   IMMUNOLOGICALLY IGNORANT AUTOREACTIVE T-CELLS, EPITOPE SPREADING AND REPERTOIRE LIMITATION [J].
ELSON, CJ ;
BARKER, RN ;
THOMPSON, SJ ;
WILLIAMS, NA .
IMMUNOLOGY TODAY, 1995, 16 (02) :71-76
[60]   AUTOREACTIVE T-CELLS IN HEALTHY-INDIVIDUALS SHOW TOLERANCE IN-VITRO WITH CHARACTERISTICS SIMILAR TO BUT DISTINCT FROM CLONAL ANERGY [J].
FILION, MC ;
BRADLEY, AJ ;
DEVINE, DV ;
DECARY, F ;
CHARTRAND, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) :3123-3127